Lumexa Imaging (LMRI) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 10, 2026, to be held virtually, with voting and Q&A available online for shareholders.

• Shareholders will vote on electing three Class I directors and ratifying PwC as the independent auditor for 2026.

• Proxy materials and annual report are available online, with voting accessible via internet, phone, or mail.

Voting matters and shareholder proposals

• Proposal 1: Elect three Class I directors (Lee Cooper, Brian Regan, Caitlin Zulla) to serve until 2029.

• Proposal 2: Ratify PwC as independent registered public accounting firm for 2026.

• Board recommends voting FOR all director nominees and FOR auditor ratification.

• Shareholders may submit proposals for the 2027 annual meeting by December 29, 2026.

Board of directors and corporate governance

• Board consists of nine members divided into three staggered classes, with annual elections for one class.

• Majority of directors are independent, with separate Chair and CEO roles.

• Five standing committees: Audit, Compensation, Nominating and Corporate Governance, Technology, and Patient Safety and Quality of Care.

• Stockholders Agreement with WCAS grants board nomination rights based on ownership percentage.